Implementation of prasugrel and prognostic outcomes after percutaneous coronary intervention for myocardial infarction: a nationwide observational study
Event: ESC Congress 2024
Topic: Antiplatelet Drugs
Session: Antiplatelet therapy: novel approaches for acute coronary syndrome and percutaneous coronary intervention
Nationwide observational study of antithrombotic treatment strategies after coronary artery bypass graft surgery in patients with atrial fibrillation
Event: ESC Congress 2023
Topic: Anticoagulants
Session: Oral anticoagulation in patients with atrial fibrillation
High bleeding risk in all-comers with ST-segment elevation myocardial infarction and use of P2Y12-inhibitiors
Event: ESC Congress 2022
Topic: Clinical
Session: Coronary artery disease
Efficacy and safety of clopidogrel, ticagrelor, and prasugrel in an all-comers population of patients with ST-segment elevation myocardial infarction
Event: ESC Congress 2020
Topic: ST-Elevation Myocardial Infarction (STEMI)
Session: Evolving Management of ST-Segment Elevation Myocardial Infarction
